GlassScriptPhysician profile
Kenneth W Jones
NPI 1659331635
$267,466.95
in general payments reported to CMS, 2019-2025
27 companies · $965 in 2025
The $965 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77K · 2020: $182K · 2021: $447 · 2022: $2,481 · 2023: $1,445 · 2024: $3,902 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,234 · Food and Beverage: $2,232 · Consulting Fee: $820 · Education: $25.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,234.19 |
| Food and Beverage | $2,231.93 |
| Consulting Fee | $820.00 |
| Education | $25.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artegraft INC. | $249,862.50 | 2019-2020 | |
| Pfizer INC. | $5,236.13 | 2019 | |
| W. L. Gore & Associates, INC. | $5,175.58 | 2021-2025 | Gore Bio-A Tissue Reinforcement, Product In Development, Gore Tag Thoracic Endoprosthesis |
| Davol INC. | $2,094.91 | 2021-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $1,338.82 | 2019-2021 | |
| Focal Therapeutics, INC. | $872.26 | 2019-2020 | |
| Hologic INC | $773.37 | 2019-2025 | Localizer, Magseed |
| Janssen Pharmaceuticals, INC | $393.58 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $325.62 | 2019-2025 | Keytruda, Lynparza |
| Tela Bio, INC. | $169.92 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Aroa Biosurgery Incorporated | $169.02 | 2022-2024 | |
| Medtronic, INC. | $166.53 | 2022-2024 | Progrip |
| Integra Lifesciences Corporation | $120.94 | 2021-2022 | |
| Novo Nordisk INC | $114.57 | 2019 | |
| Acell, INC. | $114.07 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $111.91 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $106.36 | 2020 | |
| Innocoll Pharmaceuticals Limited | $69.92 | 2021-2022 | |
| Access Pro Medical, LLC | $68.24 | 2023 | Matriderm |
| Shire North American Group INC | $38.18 | 2019 | |
| Smith+Nephew, INC. | $35.90 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.99 | 2022 | |
| Hologic Sales and Service, LLC | $23.11 | 2022 | |
| Exact Sciences Corporation | $21.91 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $13.65 | 2019 | |
| Biocomposites INC | $13.61 | 2019 | |
| Heron Therapeutics, INC. | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.